These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35549672)

  • 1. Improving individualized prescription in patients with multimorbidity through medication review.
    Molist-Brunet N; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Barneto-Soto M; González-Bueno J; Espaulella-Panicot J
    BMC Geriatr; 2022 May; 22(1):417. PubMed ID: 35549672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with the Detection of Inappropriate Prescriptions in Older People: A Prospective Cohort.
    Molist-Brunet N; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Espaulella-Ferrer M; Amblàs-Novellas J; Espaulella-Panicot J
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized Medication Review in Older People with Multimorbidity: A Comparative Analysis between Patients Living at Home and in a Nursing Home.
    Molist-Brunet N; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Bajo-Peñas L; Cantizano-Baldo I; Cabanas-Collell L; Espaulella-Panicot J
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study.
    Espaulella-Ferrer M; Molist-Brunet N; Espaulella-Panicot J; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Otero-Viñas M
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity.
    González-Bueno J; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Molist-Brunet N; Codina-Jané C; Espaulella-Panicot J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):127-137. PubMed ID: 34448906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic optimization through goal-oriented prescription in nursing homes.
    Molist-Brunet N; Sevilla-Sánchez D; González-Bueno J; Garcia-Sánchez V; Segura-Martín LA; Codina-Jané C; Espaulella-Panicot J
    Int J Clin Pharm; 2021 Aug; 43(4):990-997. PubMed ID: 33247821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
    O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study.
    Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T
    Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
    McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
    PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Very elderly institutionalised population of Barcelona: Evaluation of frailty according to the Frail-VIG index and analysis of therapeutic appropriateness according to the STOPP-frail criteria].
    Vivanco MV; Formiga F; Mundet Riera I; San José Laporte A; Curto Prieto D
    Rev Esp Geriatr Gerontol; 2019; 54(6):334-338. PubMed ID: 31362844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.
    Zhang X; Zhou S; Li X; Zhou W; Zhou Y; Cui Y; Liu X
    Int J Clin Pharm; 2019 Oct; 41(5):1152-1158. PubMed ID: 31392583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of Medications in Older Adults Living With Frailty: Impact of a Pharmacist-Led Structured Medication Review Process in Primary Care.
    Khera S; Abbasi M; Dabravolskaj J; Sadowski CA; Yua H; Chevalier B
    J Prim Care Community Health; 2019; 10():2150132719890227. PubMed ID: 31808725
    [No Abstract]   [Full Text] [Related]  

  • 14. Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial.
    Jamieson H; Nishtala PS; Bergler HU; Weaver SK; Pickering JW; Ailabouni NJ; Abey-Nesbit R; Gullery C; Deely J; Gee SB; Hilmer SN; Mangin D
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1692-1700. PubMed ID: 36692224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand.
    Duncan S; Bergler HU; Menclova A; Pickering JW; Nishtala PS; Ailabouni N; Hilmer SN; Mangin D; Jamieson H
    Value Health Reg Issues; 2024 May; 41():72-79. PubMed ID: 38245933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial.
    van der Meer HG; Wouters H; Pont LG; Taxis K
    BMJ Open; 2018 Jul; 8(7):e019042. PubMed ID: 30030308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians.
    Harris DA; Guo Y; Nakhla N; Tadrous M; Hogan DB; Hennessy D; Langlois K; Garner R; Leslie S; Bronskill SE; Heckman G; Maxwell CJ
    Health Rep; 2022 Jun; 33(6):3-16. PubMed ID: 35876612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing in the oldest old inpatients: a retrospective analysis of patients referred for specialist geriatric consultation.
    Ilango S; Pillans P; Peel NM; Scott I; Gray LC; Hubbard RE
    Intern Med J; 2017 Sep; 47(9):1019-1025. PubMed ID: 28632340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.